A look back at this week's news.
Placental cord drainage may be the key to managing the third stage of labor, according to research in BMC Pregnancy and Childbirth.
Mycovia Pharmaceuticals recently announced US availability of oteseconazole capsules for the treatment of recurrent vulvovaginal candidiasis in women without reproductive potential.
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.
ObsEva plans to drop linzagolix, its leading candidate for the treatment of uterine fibroids, following concerns raised by the FDA.
Socioeconomic disadvantage in pregnancy linked to postpartum CVD risk
February 19th 2025A new study highlights how neighborhood-level socioeconomic deprivation in early pregnancy significantly raises the long-term risk of cardiovascular disease in postpartum women, emphasizing the role of social determinants in maternal health.
Read More
Maternal hypertension and diabetes linked to worse offspring cardiovascular health
February 17th 2025A new study finds that children born to mothers with hypertensive disorders of pregnancy or gestational diabetes are at a higher risk of developing cardiovascular health issues by ages 10 to 14 years.
Read More